Dr. Jonathan K. Mays, MD is a board-certified maternal-fetal medicine specialist at New York Metropolitan Hospital Center where he serves as Deputy Director of Obstetrics and Maternal-Fetal Medicine. He is an Assistant Professor of Obstetrics and Gynecology at New York Medical College. He has published several papers in the area of maternal-fetal medicine, with specific emphasis on Intrahepatic Cholestasis of Pregnancy. Dr. Mays has studied approaches to active management of Intrahepatic Cholestasis of Pregnancy and the ideal time to intervene with induction of labor. He is currently working on a research project to investigate the genetics of Intrahepatic Cholestasis of Pregnancy.

Dr. Victor Hugo González-Quintero, MD, MPH is former Professor and Director of the Obstetrics and Gynecology Residency Program at the Miller School of Medicine, University of Miami. Dr. Victor Hugo González-Quinteros is a board-certified maternal-fetal medicine specialist. He has been published widely in peer review journals on many subjects, including multiple pregnancies, gestational diabetes, prenatal diagnosis, and high-risk pregnancies. His work has been recognized by CREOG (Council on Resident Education in Obstetrics and Gynecology) and ACOG (American congress of Obstetricians and Gynecologists). His current practice is in Miami, FL at Associates in Advanced Maternal Fetal Medicine that are specialists in perinatal health.

Dr. Maria Cecilia Estiú

University of Salamanca (Spain), Doctor in Pharmacology and Cellular and Molecular Physiology, Laureate Ph.D. from the University of Salamanca (Spain) for her research on Intrahepatic Cholestasis of Pregnancy, Master in Pharmacology and Cellular and Molecular Physiopathology, Austral University (Argentina), Master in Clinical and Pharmacological Research, Faculty of Medical Sciences of the National University of La Plata (Argentina), Specialist in Obstetrics and Gynecology Medical Doctor (MD)

Main Actions and Functions

Coordinator of Clinical Research Group in ICP since 2004 at Sarda Materno Infantil Hospital (Argentina), Expert referent for different counties in ICP, led government of forts objectively reducing mother and child mortality in Argentina, influenced clinical practice guidelines for Intrahepatic Cholestasis of Pregnancy, coordinated multiple  international research projects in pre-eclampsia and ICP and trained medical professionals across multiple regions.

Dr. Jordan Perlow, MD is a board-certified in Obstetrics and Gynecology and Maternal & Fetal Medicine. He is clinical Professor at University of Arizona College of Medicine – Phoenix, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine. He is a member of the Society for Maternal-Fetal Medicine and regularly serves as a judge of scientific papers for the organization at its annual clinical meeting. He is a reviewer of research submitted for publication in the American Journal of Obstetrics & Gynecology and Obstetrics and Gynecology. He has academic appointments as Clinical Professor, University of Arizona College of Medicine. He has lectured throughout the world, including India, the Philippines, Kuala Lumpur Malaysia, Brazil, Mexico and Israel. Dr. Perlow is immediate-past Director of Maternal-Fetal Medicine at Banner Good Samaritan Medical Center, where he has provided maternal-fetal medicine care for 28 years and co-led the establishment of a world-class center of excellence for the management of patients with the highly life-threatening complication of invasive placentation.

Dr. Laura Bonebrake, MD is a board-certified physician in Obstetrics and Gynecology with over 10 years of practice experience. She is currently employed as an OB Hospitalist with SSM Health in St. Louis, Missouri. She completed her medical school at Creighton University School of Medicine and her residency in Obstetrics and Gynecology at the University of Iowa. She has an interest in ensuring appropriate care for patients with Intrahepatic Cholestasis of Pregnancy within her hospital system and has helped shape pediatric practices at her institution to allow for an appropriate response at delivery for these neonates. She also serves on the board of directors of ICP Care and has served in this role since 2020. This role allows her to help interpret the current research and guidelines and produce educational materials that are beneficial for both physicians and patients.